Skip to content

HbA1C CONTROL HA5072

by Randox Laboratories, Ltd.

HbA1C CONTROL HA5072 is a Class I device made by Randox Laboratories, Ltd., cleared under FDA 510(k) K131999 on 26 Jul 2013 and listed in FDA GUDID since 16 Sep 2016 (UDI-DI 05055273208818), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K131999

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05055273208818 UDI-DI Date16 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK131999 Date26 Jul 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K131999 decided 26 Jul 2013 Active
  • FDA GUDID UDI-DI 05055273208818 listed 16 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K131999
  2. Listed FDA GUDID 05055273208818

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
HbA1C CONTROL
Generic name
Glycated haemoglobin (HbA1c) IVD, control
Model / Ref / Catalog
HA5072
Primary DI / UDI-DI
05055273208818
510(k) Number
FDA product code
JJX
GMDN term
Glycated haemoglobin (HbA1c) IVD, control
Device class
Class I
Regulation number
862.1660
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Glycated haemoglobin (HbA1c) IVD, control.

Other devices from Randox Laboratories, Ltd.

See all devices from Randox Laboratories, Ltd. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)